Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients

Detection Principle
IgG/IgM and IgG/IgA
Testing Method Category
Testing Method
Multiple kits
Testing Method - Additional Info
7 rapid IgG/IgM tests (LFA lateral flow assays) and the Euroimmun IgA/IgG ELISA
Reported Performance
Specificity: ?91.3% (LFA, IgM), ?90.3% (LFA, IgG), ?85.4% (LFA, IgM OR IgG), 96.1% (ELISA, IgG), 73.8% (ELISA, IgA); Sensitivity: 92.1%-100% ( IgG LFA, 14-25 dpo), 89.5% (IgG ELISA, 14-25 dpo)
Sample Size
103 samples (specificity), 167 samples (sensitivity)

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements